Porth's Essentials of Pathophysiology, 4e

792

Endocrine System

U N I T 9

24. Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Pediatrics. 1999;104:936–941. 25. Cooper DS, Greenspan FS, Ladenson PW. The thyroid gland. In: Gardner DG, Shoback D, eds. Basic and Clinical Endocrinology . 9th ed. New York, NY: Lange Medical Books/McGraw-Hill Medical; 2011:163–226. 26. Guyton AC, Hall JE. Medical Physiology . 12th ed. Philadelphia, PA: Elsevier Saunders; 2012:907–920. 27. Koulouri O, Gurnell M. Interpretation of thyroid function tests. Clin Med. 2013;13:282–286. 28. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:2646–2655. 29. Devdhar M, Ousman YH, Burman KD. Hypothyroidism. Endocrinol Metab Clin North Am. 2007;36:595–615. 30. Fatourechl V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65–71. 31. Wartofsky L. Myxedema coma. Endocrinol Metab Clin North Am. 2006;35:687–698. 32. Cooper DS. Hyperthyroidism. Lancet. 2003;362:459–468. 33. Pearce EN, Hennessey JV, McDermott MT. New American Thyroid Association and American Association of Clinical Endocrinologists guidelines for thyrotoxicosis and other forms of hyperthyroidism: significant progress for the clinician and a guide to future research. Thyroid. 2011;21:573–576. 34. McKenna TJ. Graves’ disease. Lancet. 2001;357:1793–1796. 35. Brent GA. Graves’ disease. N Engl J Med. 2008;358(24):2594–2605. 36. Bartalena L, Tanda ML. Graves’ ophthalmopathy. N Engl J Med. 2009;360(10):994–1001. 37. Bahn R. Pathophysiology of Graves’ ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab. 2003;88:1939–1946. 38. Matfin G. Endocrine and metabolic emergencies: thyroid storm. Ther Adv Endocrinol Metab. 2010;3:139–145. 39. Aron DC, Findling JW, Tyrrell JB, et al. Glucocorticoids and adrenal androgens. In: Gardner DG, Shoback D, eds. Basic and Clinical Endocrinology . 9th ed. New York, NY: Lange Medical Books/McGraw-Hill Medical; 2011:285–328.

40. Newell-Price J, Bertagna X, Grossman AB, et al. Cushing’s syndrome. Lancet. 2006;367:1605–1617. 41. Pivonello R, Cristina M, DeMartino CM, et al. Cushing’s syndrome. Endocrinol Metab Clin North Am. 2008;37: 135–149. 42. White PC, Bachega T. Congenital adrenal hyperplasia. Semin Reprod Med. 2012;30:400. 43. Boos CJ, Rumsby G, Matfin G. Multiple tumors associated with late onset congenital hyperplasia due to aberrant splicing of adrenal 21-hydroxylase gene. Endocr Pract. 2002;8:470–473. 44. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361:1881–1893. 45. Bouillon R. Acute adrenal insufficiency. Endocrinol Metab Clin North Am. 2006;35:767–775. 46. Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med. 2009;360(22):2328–2339. 47. Raff H, Findling JW. A physiological approach to the diagnosis of Cushing’s syndrome. Ann Intern Med. 2003;138:980–991. 48. Nieman LK, Ilias I. Evaluation and treatment of Cushing’s syndrome. Am J Med. 2005;118:1340–1346. 49. Gopan T, Remer E, Hamrahian AH. Evaluating and managing adrenal incidentalomas. Cleve Clin J Med. 2006;73:561–568. 50. Grumbach MM, Biller BMK, Braunstein GD, et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med. 2003;138:424–429.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Concepts in Action Animations • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu